Innovation Pharmaceuticals Inc (IPIX)

[windansea]

but not testing for efficacy quite yet

Pregressive: thanks for the clarification on which CTIX "clinical" test today's PR is about. My understanding is the the study subjects will be taking the Prurisol pills and then their blood will be draw and tested after a certain period of time to verify that the Prurisol has been converted to the chemical signature of Abacavir. The part about "no efficacy testing" must be imposed by FDA boilerplate requirements. Surely test subjects and personnel running the tests will be able to see if Pruisol is having any dramatic effects. Will FDA rules require that such observations be considered as "anecdotal" and thus unreportable until the real Phase 2/3 is completed? My interest stems from the fact that my wife experiences periodic outbreaks of psoriasis. While her affliction is mild compared to some the psoriasis photos I have seen on the internet, its bad enough. GO Prurisol!